Ree AH, Nygaard V, Boye K, Heinrich D, Dueland S, Bergheim IR, Johansen C, Beiske K, Negård A, Lund-Iversen M, Nygaard V, Hovig E, Nakken S, Nasser S, Julsrud L, Reisse CH, Ruud EA, Kristensen VN, Flørenes VA, Geitvik GA, Lingjærde OC, Børresen-Dale AL, Russnes HG, Mælandsmo GM, Flatmark K(2020) Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study Acta Oncol, 1-8(in press) DOI 10.1080/0284186X.2020.1742377, PubMed 32208873
Møller P(2020) The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care Hered Cancer Clin Pract, 18, 6 DOI 10.1186/s13053-020-0138-0, PubMed 32190163
Møller P, Dominguez-Valentin M, Rødland EA, Hovig E(2020) Correction: Møller, P.; et al. Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. Cancers 2019, 11, 132 Cancers (Basel), 12(2) DOI 10.3390/cancers12020410, PubMed 32050665